Showing 1 - 10 of 14
Persistent link: https://www.econbiz.de/10011500056
Financial ties between drug companies and medical researchers are thought to bias results published in medical journals. To enable readers to account for such bias, most medical journals require authors to disclose potential conflicts of interest. For such policies to be effective, conflict...
Persistent link: https://www.econbiz.de/10014234349
Persistent link: https://www.econbiz.de/10010243020
In recent years, reporting under International Financial Reporting Standards (IFRS) became mandatory in many countries. The capital-market effects around this change have been extensively studied, but their sources are not yet well understood. This study aims to distinguish between several...
Persistent link: https://www.econbiz.de/10010729559
Persistent link: https://www.econbiz.de/10003835861
Persistent link: https://www.econbiz.de/10003747381
Persistent link: https://www.econbiz.de/10001848606
estimate shocks to firms' betas around the Enron events and the ensuing transparency crisis. Our analysis shows that these beta … that firms' disclosure responses reduce firms' costs of capital and hence the impact of the transparency crisis …
Persistent link: https://www.econbiz.de/10012757529
estimate shocks to firms' betas around the Enron events and the ensuing transparency crisis. Our analysis shows that these beta … that firms' disclosure responses reduce firms' costs of capital and hence the impact of the transparency crisis …
Persistent link: https://www.econbiz.de/10012463751
Financial ties between drug companies and medical researchers are thought to bias studies published in medical journals. To enable readers to account for such bias, most medical journals require authors to disclose potential conflicts of interest. We examine whether disclosure reduces article...
Persistent link: https://www.econbiz.de/10014226124